ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 236

Foot and Ankle Muscle Strength in People with Gout: A Two-Arm Cross-Sectional Study

Sarah Stewart1, Grant Mawston2, Lisa Davidtz3, Nicola Dalbeth4, Alain Vandal5, Matthew Carroll3, Trish Morpeth6, Simon Otter7 and Keith Rome8, 1School of Podiatry, Auckland University of Technology, Auckland, Niger, 2Department of Physiotherapy, Auckland University of Technology, Auckland, New Zealand, 3School of Podiatry, Auckland University of Technology, Auckland, New Zealand, 4Department of Medicine, University of Auckland, Auckland, New Zealand, 5Counties Manukau District Health Board, Auckland, New Zealand, 6Auckland University of Technology, Auckland, New Zealand, 7School of Health Professions, University of Brighton, Brighton, England, 8Health & Research Rehabilitation Centre, AUT University, Auckland, AR, New Zealand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankle, foot, gout and muscle strength

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Metabolic and Crystal Arthropathies Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:
Foot and ankle structures are commonly affected in gout. People with gout
experience difficulty walking and report high levels of foot pain, disability
and impairment. Despite the importance of lower limb and foot muscle strength requirements
in walking, the strength of foot and ankle muscles in gout is unknown. The
primary aim of this study was to determine differences in foot and ankle muscle
strength for ankle plantarflexion, dorsiflexion, inversion and eversion between
people with gout and age- and sex-matched controls. The secondary aim was to
examine the relationship between foot and ankle muscle strength, and foot pain
and disability.

Methods: Peak
isokinetic concentric muscle torque was measured for ankle plantarflexion, dorsiflexion,
eversion and inversion in 20 participants with gout and 20 matched controls at
two testing velocities (30°/s and 120°/s) using a Biodex
dynamometer. Peak torque was calculated and normalised to body weight. Foot
pain and disability was measured using the Manchester Foot Pain and Disability
Index (MFPDI). Differences in peak torque between gout and control participants
were analysed using mixed linear models. Pearson’s correlation coefficients
were used to determine associations between MFPDI scores and peak torque.

Results: Differences
in peak torque between gout participants and controls are displayed in the
Table below. At both the 30°/s
and 120°/s testing
velocities, participants with gout had lower ankle peak plantarflexion,
inversion, and eversion torque compared with control participants. No
differences between gout and control participants were evinced for peak
dorsiflexion torque at either 30°/s
or 120°/s testing velocities. Mean MFPDI scores were higher in
participants with gout compared to controls (p=0.00001). For participants with
gout, MFPDI scores were inversely correlated with peak plantarflexion torque at
both 30°/s (r=-0.66,
p<0.001) and 120°/s
(r=-0.44, p=0.008), peak eversion torque at the 120°/s testing velocity (r=-0.36,
p=0.045) and peak inversion torque at both 30°/s (r=-0.49, p=0.005)
and 120°/s (r=-0.56, p=0.001) testing velocities.

Conclusion: People
with gout have reduced foot and ankle muscle strength and experience greater
foot pain and disability compared to controls. Foot and ankle strength
reductions are strongly associated with increased foot pain and disability in
people with gout.

 

Table. Mean peak torque and difference between gout and controls, N·m/kg

 

Mean (SD) peak torque

Difference (95% CI)

p

 

Control

Gout

Plantarflexion 30°/s

0.94 (0.10)

0.65 (0.10)

-0.29 (-0.51, -0.07)

0.010

Dorsiflexion 30°/s

0.41 (0.08)

0.37 (0.09)

-0.04 (-0.10, 0.03)

0.280

Plantarflexion 120°/s

0.51 (0.19)

0.32 (0.19)

-0.19 (-0.32, -0.05)

0.008

Dorsiflexion 120°/s

0.25 (0.14)

0.22 (0.14)

-0.03 (-0.06, 0.01)

0.111

Eversion 30°/s

0.34 (0.07)

0.24 (0.07)

-0.09 (-0.16, -0.03)

0.005

Inversion 30°/s

0.37 (0.30)

0.25 (0.30)

-0.12 (-0.21, -0.03)

0.012

Eversion 120°/s

0.21 (0.15)

0.17 (0.15)

-0.04 (-0.08, -0.01)

0.028

Inversion 120°/s

0.24 (0.48)

0.17 (0.48)

-0.07 (-0.12, -0.02)

0.005

 

 


Disclosure: S. Stewart, None; G. Mawston, None; L. Davidtz, None; N. Dalbeth, Takeda, AstraZeneca, Pfizer, 5,AstraZeneca, 8,Ardea Biosciences, 2; A. Vandal, None; M. Carroll, None; T. Morpeth, None; S. Otter, None; K. Rome, None.

To cite this abstract in AMA style:

Stewart S, Mawston G, Davidtz L, Dalbeth N, Vandal A, Carroll M, Morpeth T, Otter S, Rome K. Foot and Ankle Muscle Strength in People with Gout: A Two-Arm Cross-Sectional Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/foot-and-ankle-muscle-strength-in-people-with-gout-a-two-arm-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/foot-and-ankle-muscle-strength-in-people-with-gout-a-two-arm-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology